ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
Sat Kartar Life proposes a 30-bed Ayurveda hospital in Jaipur at an estimated ₹1.25 Crore investment. The facility is expected to be operational by March 2027.
Sat Kartar Life received NSE in-principle approval to list 5,50,000 equity shares from warrant conversion. Approval is subject to listing application and allottee undertakings.
Sat Kartar Life proposes a 25-bed Ayurveda hospital-cum-therapy centre in Lucknow at ₹1 Crore investment. Expected operational by February 2027 as part of its healthcare network expansion.
Sat Kartar Life is pivoting from pure Ayurveda products to an integrated healthcare model, showing strong revenue growth but scaling back prior top-line guidance to prioritize margins.
Sat Kartar Life Ltd reported revenue from operations of ₹113.9 Cr (+26.4% YoY) and net profit of ₹9.2 Cr (+26.0% YoY) for H1 FY27.
H1 FY27 deck discloses no revenue, PAT or EBITDA figures. Balance sheet is debt-free with ₹18.7 Cr net cash. Growth is hospital-led: 30-bed Delhi unit at breakeven, 300 beds targeted by FY27-end.
Sat Kartar Life Limited reported H1 FY27 revenue growth of 26% and EBITDA growth of 48% via press release. Its first Ayurveda hospital reached operating breakeven.
Sat Kartar Life filed CARE Ratings' IPO proceeds monitoring report for half year ended September 2026. It shows nil deviation from objects, so no new event occurred.
Sat Kartar Life's EGM covered one special resolution to issue fully convertible warrants to promoter group on preferential basis. Voting results follow within two working days.
Sat Kartar Life Limited proposes a new 1,050 sq ft Day Care Therapy Centre in Gurugram, expected by November 2026. Investment is approximately Rs.15 Lacs, funded by IPO proceeds and internal accruals.
Sat Kartar Life Limited proposes to establish a new hospital-cum-therapy centre in Amritsar, Punjab, with an investment of ₹1.5 Crore and a 30-bed capacity.
Sat Kartar Life Limited will hold a board meeting on 24-Oct-2026 to consider and approve its unaudited financial results for the half year ended September 2026.
Sat Kartar Life Limited informed the exchange that the Corporate Governance Report is not applicable to the company for the quarter ended September 30, 2026.
Sat Kartar Life Limited has issued a notice for an Extra-ordinary General Meeting (EGM) to be held on October 23, 2026. The meeting agenda includes the preferential issuance of fully convertible warrants.
Sat Kartar Life Ltd scheduled an EGM on October 23, 2026, to approve the preferential issue of warrants worth ₹9.46 Crore to its promoters.
Sat Kartar Life Limited's board approved a preferential issue of 5,50,000 convertible warrants to promoters at ₹172 each. The total capital raise is valued at ₹9.46 Crore.
Sat Kartar Life signed an LOI for a 20-bed hospital-cum-therapy centre in Dehradun at ₹0.70 Crore. The facility is expected to be operational by December 2026.
Sat Kartar Life Limited has re-appointed M/s. Nidhi Bansal & Co. as its statutory auditor for a further term of five consecutive years.
Sat Kartar Life Limited held its 14th Annual General Meeting on August 28, 2026. Shareholders considered financial statements, director re-appointments, auditor appointments, and a final dividend of Rs.0.70.
Sat Kartar Life Limited plans to establish a new hospital-cum-therapy centre in Gurugram with a ₹1 crore investment. The facility will feature 10-15 beds.
Sat Kartar Life Limited announced the dispatch of letters to unregistered shareholders, providing a web link to access the Annual Report 2025-2026 for the upcoming AGM.
Sat Kartar Life Limited has issued a notice for its 14th Annual General Meeting, scheduled for August 28, 2026, to transact ordinary and special business.
Sat Kartar Life Limited re-appointed M/s. Nidhi Bansal & Co as Statutory Auditors for a five-year term. The board approved this decision during its meeting on July 31, 2026.
Sat Kartar Life Limited recommended a final dividend of ₹0.70 per equity share for FY2026. The board fixed August 21, 2026, as the record date for payment.
Sat Kartar Life Limited has entered into a common empanelment agreement with the General Insurance Council to facilitate cashless medical treatment.
Sat Kartar Life Ltd received NSE trading approval for 50,400 preferentially allotted shares. The shares are locked in till January 29, 2027.
Sat Kartar Life Limited commenced commercial operations in the USA via its subsidiary. The company established an office in Texas to expand its global wellness presence.
Sat Kartar Life expanded its global footprint by commencing operations in the USA. The expansion involves establishing a subsidiary and office in Texas.
Sat Kartar Life Limited received NABH accreditation for its hospital, valid until May 2029. This enhances patient confidence and supports future empanelments.
Sat Kartar Life Limited received NABH Accreditation for its Sanjeevan Hospital in New Delhi. This certification validates service quality and supports future healthcare empanelment opportunities.